Conference Coverage (ISV)

1996-97 Flu Vaccine Recall A Black Eye For Vaccinology

Published in Vaccine Weekly, September 22nd, 1997

The recall of the Parke-Davis 1996-97 influenza vaccine was ill-advised and has hurt the overall vaccination effort, according to the chief of the Mayo Clinic Vaccine Research Group.

The manufacturer voluntarily recalled 11 lots of the vaccine - already administered to 2 million Americans - after a controversial U.S. Centers for Disease Control and Prevention (CDC) study showed that one of the its three components may have had lowered potency. There were no safety problems with the Parke-Davis product.

"In my own mind, I find it hard to justify a recall on this basis," said Mayo Clinic researcher Gregory Poland in an address to the first annual...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1997-09-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry